Will Pharmacogenetics Predict Response to Therapies in Rheumatoid Arthritis?
Pp. 307-319 Happy Chan and Prabha Ranganathan [Abstract] Pharmacogenomics and Severe Infections: The Role of the Genomes of Both the Host and the Pathogen Pp. 321-329 G. Sirgo, J. Rello and G. Waterer [Abstract] Pharmacogenomics of the Human ATP-Binding Cassette Transporter ABCG2 Pp. 331-344 Erin R. Gardner, William D. Figg and Alex Sparreboom [Abstract] Polymorphisms of Genes Encoding Phase I Enzymes in Mexican Americans – An Ethnic Comparison Study Pp. 345-353 Huai-Rong Luo and Yu-Jui Yvonne Wan [Abstract] Abstracts [Back to top] Pharmacogenomic Approaches to Osteoporosis: 2005 Update Yuan Chen, Dong-Hai Xiong, Hui Jiang and Hong-Wen Deng Osteoporosis is a skeletal disorder characterized by compromised bone strength predisposing a person to an increased risk of fracture. The overall rate of osteoporosis is increasing annually around the world, especially among the elderly people, resulting in heavier social-economic burden. Till now, certain anti-osteoporosis medications have been ap
